|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 558.00 CHF | -0.46% |
|
+3.79% | +3.76% |
| 14/01 | Lonza Group AG Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 10:30 AM | |
| 18/12 | Swiss trade surplus at CHF 3.841 bln in November | RE |
Company Valuation: Lonza Group AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 42,255 | 56,574 | 33,615 | 26,273 | 38,699 | 39,188 | 39,188 | - |
| Change | - | 33.89% | -40.58% | -21.84% | 47.29% | 1.26% | 0% | - |
| Enterprise Value (EV) 1 | 45,068 | 55,616 | 33,429 | 27,195 | 41,558 | 42,623 | 42,689 | 42,506 |
| Change | - | 23.4% | -39.89% | -18.65% | 52.81% | 2.56% | 0.15% | -0.43% |
| P/E ratio | 48.9x | 19.3x | 27.7x | 39.8x | 60.1x | 38.8x | 32.1x | 26.4x |
| PBR | 6.2x | 5.82x | 3.18x | 2.76x | 4.1x | 4x | 3.68x | 3.34x |
| PEG | - | 0x | -0.5x | -0.9x | 133.42x | 0.6x | 1.5x | 1.2x |
| Capitalization / Revenue | 6.83x | 10.5x | 5.4x | 3.91x | 5.89x | 5.18x | 4.76x | 4.26x |
| EV / Revenue | 7.29x | 10.3x | 5.37x | 4.05x | 6.32x | 5.63x | 5.18x | 4.62x |
| EV / EBITDA | 26.1x | 33.4x | 16.8x | 13.6x | 21.8x | 18.9x | 16.7x | 14.4x |
| EV / EBIT | 33.2x | 48.3x | 23.9x | 29x | 35.3x | 27.6x | 23.9x | 20x |
| EV / FCF | 287x | -449x | -39.2x | -91.6x | -291x | 221x | 101x | 56x |
| FCF Yield | 0.35% | -0.22% | -2.55% | -1.09% | -0.34% | 0.45% | 0.99% | 1.79% |
| Dividend per Share 2 | 3 | 3 | 3 | 4 | 4 | 4.939 | 5.583 | 6.62 |
| Rate of return | 0.53% | 0.39% | 0.66% | 1.13% | 0.75% | 0.89% | 1% | 1.19% |
| EPS 2 | 11.63 | 39.52 | 16.34 | 8.88 | 8.92 | 14.38 | 17.4 | 21.13 |
| Distribution rate | 25.8% | 7.59% | 18.4% | 45% | 44.8% | 34.3% | 32.1% | 31.3% |
| Net sales 1 | 6,185 | 5,409 | 6,223 | 6,717 | 6,574 | 7,568 | 8,238 | 9,203 |
| EBITDA 1 | 1,728 | 1,665 | 1,995 | 1,999 | 1,908 | 2,259 | 2,556 | 2,954 |
| EBIT 1 | 1,358 | 1,151 | 1,397 | 939 | 1,177 | 1,547 | 1,788 | 2,122 |
| Net income 1 | 869 | 2,944 | 1,215 | 654 | 636 | 1,027 | 1,240 | 1,498 |
| Net Debt 1 | 2,813 | -958 | -186 | 922 | 2,859 | 3,436 | 3,502 | 3,318 |
| Reference price 2 | 568.80 | 761.60 | 453.10 | 353.70 | 535.80 | 558.00 | 558.00 | 558.00 |
| Nbr of stocks (in thousands) | 74,289 | 74,283 | 74,189 | 74,282 | 72,226 | 70,229 | 70,229 | - |
| Announcement Date | 27/01/21 | 26/01/22 | 25/01/23 | 26/01/24 | 29/01/25 | - | - | - |
1CHF in Million2CHF
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 38.98x | 5.66x | 18.94x | 0.88% | 4.91TCr | ||
| 34.02x | 3.37x | 14.4x | -.--% | 4.11TCr | ||
| 107.41x | 6.89x | 69.31x | -.--% | 3.88TCr | ||
| 58.35x | 11.95x | 33.22x | 0.33% | 3.27TCr | ||
| -21.47x | 6231.22x | -20.36x | -.--% | 2.32TCr | ||
| 41.11x | 6.66x | 30.29x | -.--% | 1.71TCr | ||
| 28.5x | 2.26x | 10.11x | 0.85% | 1.5TCr | ||
| 27.2x | 2.11x | 10.77x | -.--% | 1.4TCr | ||
| -35.02x | 13.31x | -35.72x | -.--% | 1.29TCr | ||
| Average | 31.01x | 698.16x | 14.55x | 0.23% | 2.71TCr | |
| Weighted average by Cap. | 40.81x | 597.80x | 21.28x | 0.27% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- LONN Stock
- Valuation Lonza Group AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















